Press Release

Clinical Decision Support System (CDSS) Market Set to Reach USD 10.71 Billion by 2030 from USD 5.30 Billion in 2023

The Global Clinical Decision Support System (CDSS) Market size was valued at USD 5.30 billion in 2023 and is projected to reach USD 10.71 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.79% during the forecast period, i.e., 2024-30, cites MarkNtel Advisors in the recent research report.

The high rates of CVDs & Cancer that require early & apt diagnosis for improved patient survival have elevated the demand for advanced healthcare technologies like clinical decision support systems (CDSS). This is because CDSS has the potential to provide healthcare professionals & patients with accurate & precise diagnoses without mistakes, thereby allowing them to start timely treatment & have increased chances of survival. Subsequently, the Global Market for Clinical Decision Support has been experiencing positive growth trends.

Further, across healthcare facilities of the world because of certain factors such as inadequate information flow, insufficiencies in training & education, poor documentation, and others, heightened occurrences of medical errors have been witnessed. Medical errors related to diagnosis could have potential negative impacts on the overall condition of the patient including increased mortality. This motivated healthcare providers to actively adopt clinical decision support systems (CDSS) that tend to reduce the occurrence of medical errors.

Additionally, as governments have realized the importance of CDSS in reducing medical errors, improving patient outcomes, reducing healthcare costs, etc., they have made investments & funding for supporting the development as well as the adoption of advanced healthcare technologies like clinical decision support systems (CDSS). Moreover, the fact that the utilization of CDSS reduces the burden of healthcare costs by allowing doctors to prescribe the right treatments leading to faster recovery and reduced hospital stays, the demand for the same has increased, propelling the market growth & market size, further states the research report, “Global Clinical Decision Support System (CDSS) Market Analysis, 2024.”

Global Clinical Decision Support System (CDSS) Market Segmentation Analysis

Treatment Planning & Drug Management Segment Expects to Hold a Considerable Market Share of the Global Clinical Decision Support System (CDSS) Market

Based on the application segment, the market is further bifurcated into, Diagnosis Support, Treatment Planning & Drug Management, Patient Monitoring & Management, and Others. The market growth has been attributed to the heightened number of cases of adverse drug reactions being recorded in many medical facilities in countries like India, the US, Saudi Arabia, Germany, etc. Due to this, there has been an elevated demand for Clinical Decision Support Systems (CDSS) to have an idea about patient medical background & possible chances of drug interactions.

Further, many patients visiting hospitals for treatments have been reported to possess drug allergies and thereby the demand for CDSS to know about such information on a prior basis to avoid dangerous consequences has seen a tremendous boost. Moreover, patients with diseases like HIV & cancer don’t always get benefits from every treatment prescribed and also their chances of survival are reduced to a minimum. As a result, healthcare providers have been actively seeking CDSS to prescribe these patients with best possible treatment and enhance their survival rates. Hence, considering the aforementioned factors, the treatment planning & drug management category’s market size will be expanding in the coming years as well.

North America to Lead the Global Clinical Decision Support System (CDSS) Market

North America would continue to hold a considerable market share of the Global Clinical Decision Support System (CDSS) Market. This has been because there have been increased visitations of elderly patients who have been suffering from chronic diseases like CVDs & cancer, thereby generating large volumes of medical data. As a result, the adoption of a Clinical Decision Support System (CDSS) to manage elevated volumes of data without causing costly mistakes has increased across the region’s healthcare facilities.

Further, the region has high mortality rates due to happening of medical errors during diagnosis, medication, etc. As a result, healthcare facilities have been motivated to adopt CDSS to help patients & reduce mortality rates by limiting the occurrence of medical errors. Subsequently, the market for Clinical Decision Support Systems (CDSS) has been experiencing positive growth trends in the North American region.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including EvidenceCare, Koninklijke Philips N.V., IBM, Inferscience, Inc., Medical Information Technology, Inc., Mckesson Corporation, Wolters Kluwer N.V., Zynx Health, Inc. (Hearst Health), Elsevier Health, Ascom Holding AG, EBSCO Information Services, Amalgam Rx, Inc., Medtronic plc, Oracle, Epic System, and Others are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the regions?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across various regions?
6. How has the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?